| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/17/2001 | US6218412 Therapy and prophylaxis of diseases where an increased concentration of interleukin-1.beta. participates in their course, for example septic shock, leukemia, hepatitis, muscular degeneration, degenerative joint diseases |
| 04/17/2001 | US6218408 Selective NPY (Y5) antagonists (bicyclics) |
| 04/17/2001 | US6218376 For treating inflammatory diseases |
| 04/17/2001 | US6218365 Serine protease inhibitors |
| 04/17/2001 | US6217845 Protein labelling |
| 04/17/2001 | CA2080475C Neuroprotective indolone and related derivatives |
| 04/12/2001 | WO2001025229A1 Amide compounds |
| 04/12/2001 | WO2001025227A2 Quinolyl propyl piperidine derivatives and their use as antibacterial agents |
| 04/12/2001 | WO2001025220A1 Triazine kinase inhibitors |
| 04/12/2001 | WO2001025210A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 04/12/2001 | WO2001025209A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/12/2001 | WO2001025200A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | WO2001025181A1 Carboxylic acid derivatives and drugs containing the same |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024796A1 1,2,4-triazole derivatives, composition, process of making and methods of use |
| 04/12/2001 | DE19948269A1 New compounds as integrin antagonists useful for treating e.g. cardiovascular disorders, rheumatoid arthritis, kidney failure, stroke, cancer, osteoporosis, psoriasis or infection |
| 04/12/2001 | CA2608807A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/12/2001 | CA2386218A1 Triazine kinase inhibitors |
| 04/12/2001 | CA2386157A1 Amide compounds |
| 04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/12/2001 | CA2383836A1 Quinolyl propyl piperidine derivatives and their use as antibacterial agents |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090912A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 04/11/2001 | EP1089998A2 Epothilone derivatives and their synthesis and use |
| 04/11/2001 | EP1089993A1 5-ht 1f? agonists |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089981A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis. |
| 04/11/2001 | EP1089980A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | EP1089977A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |
| 04/11/2001 | EP1089735A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 04/11/2001 | EP0984963B1 Novel compounds |
| 04/11/2001 | CN1291190A 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonist |
| 04/11/2001 | CN1064359C Diindole heterocyclic compounds, preparing method and its use |
| 04/11/2001 | CN1064358C Benyl piperidine derivatives |
| 04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
| 04/10/2001 | US6215016 Hematopoietic agents; preventing cytopenia |
| 04/10/2001 | US6214996 Naphthalene derivates, process for the preparation thereof, and intermediates therefor |
| 04/10/2001 | US6214991 3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-n-acetic acid, ethyl ester for example; treating complications of diabetes mellitus, such as cataracts, retinopathy, nephropathy, and neuropathy |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
| 04/10/2001 | US6214853 Selective NPY (Y5) antagonists (bicyclics) |
| 04/10/2001 | US6214852 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 04/10/2001 | US6214845 Insecticidal N-(substituted arylmethyl)-4[bis(substituted phenyl or pyridyl)methyl] piperidines |
| 04/10/2001 | US6214842 Treating metabolic disorders related to insulin resistance or hyperglycemia typically associated with obesity or glucose intolerance; treating diabetes types i and ii |
| 04/10/2001 | US6214841 Anticoagulants |
| 04/10/2001 | US6214834 Angiogenesis inhibitors; antiinflammatory agents; anticancer agents |
| 04/10/2001 | US6214825 Aza-heterocycloakenes, pesticidal compositions containing them, pesticidal methods of using them, and processes for preparing them |
| 04/10/2001 | US6214822 Substituted aza and diazacycloheptane and cyclooctane compounds and their use |
| 04/10/2001 | US6214813 Azopyrazoles |
| 04/05/2001 | WO2001023382A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/05/2001 | WO2001023378A1 Pharmaceutically active sulfonamide derivatives |
| 04/05/2001 | WO2001023376A1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 04/05/2001 | WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/05/2001 | WO2001023357A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/05/2001 | WO2001022966A1 Caspases and apoptosis |
| 04/05/2001 | WO2000073284A3 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 04/05/2001 | WO2000068198A3 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 04/05/2001 | CA2385001A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/05/2001 | CA2352957A1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 04/04/2001 | EP1088822A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/04/2001 | EP1088821A1 Pharmaceutically active sulfonamide derivatives |
| 04/04/2001 | EP1088819A2 6-azauracil derivatives as thyroid receptor ligands |
| 04/04/2001 | EP1087981A2 Prenyl transferase inhibitors |
| 04/04/2001 | EP1087975A2 Epothilone minor constituents |
| 04/04/2001 | EP1087967A1 1,3-oxazoline and 1,3-thiazoline derivatives, method for producing the same and their use as pesticides |
| 04/04/2001 | EP1087963A1 Inhibitors of glycogen synthase kinase 3 |
| 04/04/2001 | EP1087962A1 Preparation of heteroaryl compounds |
| 04/04/2001 | EP1087959A1 Novel benzopyran or thiobenzopyran derivatives |
| 04/04/2001 | EP1087951A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 04/04/2001 | EP1087948A1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators |
| 04/04/2001 | EP1087941A2 Thiolesters and uses thereof |
| 04/04/2001 | EP1087937A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 04/04/2001 | EP0805805B1 Substituted arylazadioxacyclo alkene fungicides |
| 04/04/2001 | CN1290266A Benzofuran-4-carboxamides and their therapeutical use |
| 04/04/2001 | CN1290265A Thrombin receptor antagonists |
| 04/04/2001 | CN1290264A Triazine angiogenesis inhibitors |
| 04/04/2001 | CN1290263A Arylpiperidine derivatives and use thereof |
| 04/04/2001 | CN1290262A Heteroaromatic derivatives |
| 04/04/2001 | CN1290250A Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/04/2001 | CN1290249A Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 04/04/2001 | CN1290165A Benzothiazole Protein tyrosine kinase inhibitors |
| 04/04/2001 | CN1290164A Inhibition of RAF kinase using substituted heterocyclic ureas |
| 04/04/2001 | CN1289773A Preparation of intermediate for thiazolylisopseudoindole dyes |
| 04/04/2001 | CN1064044C Heterocyclic compounds, their production and use |
| 04/04/2001 | CN1063942C Use of thiazolidine derivative for making medicaments |
| 04/03/2001 | US6211412 Reacting beta-keto ester with hydrogenating agent in presence of asymmetric organometallic molecular catalyst comprising metal atom having one or more chiral ligands coupled thereto, converting hydroxyester formed to epothilone precursor |
| 04/03/2001 | US6211381 Chemical intermediates |
| 04/03/2001 | US6211379 Process for preparing heterocyclic compounds |
| 04/03/2001 | US6211376 8-hydroxy-7-substituted quinolines as anti-viral agents |
| 04/03/2001 | US6211240 O-benzyl oxime ether derivatives and their use as pesticides |
| 04/03/2001 | US6211234 Substituted phenyl compounds |
| 04/03/2001 | US6211214 Pesticides, insecticides or miticides |
| 04/03/2001 | US6211204 Thiadiazole, hydrogenated pyridine derivatives |
| 04/03/2001 | US6211183 Selective factor Xa inhibitors |
| 04/03/2001 | US6211178 Antiprotozoa agents for coccidioides; cyclization |
| 04/03/2001 | US6211170 Azetidinone derivatives for the treatment of HCMV infections |